Form 8-K Opexa Therapeutics, Inc. For: Aug 12
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
- Citi cuts investment banking analyst program to two years - Bloomberg
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Nasdaq notches record high close as investors focus on earnings
- This multi-trillion stock is "cheap and getting cheaper": Morgan Stanley
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
Opexa Therapeutics (OPXA) Tops Q2 EPS by 1c
August 12, 2015 4:50 PM EDTOpexa Therapeutics (NASDAQ: OPXA) reported Q2 EPS of ($0.07), $0.01 better than the analyst estimate of ($0.08).
For earnings history and earnings-related data on Opexa Therapeutics (OPXA) click here.
... More


